The table contains 9 products whose active ingredient are classified under the same pharmacologic class Prostacyclin Receptor Agonists [MoA].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 66215-602 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-604 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-606 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-608 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-610 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-612 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-614 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-616 | Uptravi | Non-Proprietary Name: Selexipag | Tablet, Coated | Oral | Actelion Pharmaceuticals Us, Inc. | ACTIVE |
| 66215-718 | Uptravi | Non-Proprietary Name: Selexipag | Injection, Powder, For Solution | Intravenous | Actelion Pharmaceuticals Us, Inc. | ACTIVE |